|
|
Volumn 359, Issue 9322, 2002, Pages 1980-1989
|
|
Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: A national cohort study in Peru
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CIPROFLOXACIN;
CLAVULANIC ACID;
ETHAMBUTOL;
ETHIONAMIDE;
ISONIAZID;
KANAMYCIN;
PYRAZINAMIDE;
SPARFLOXACIN;
ABDOMINAL PAIN;
ADOLESCENT;
ADULT;
ANOREXIA;
ARTHRALGIA;
ARTICLE;
BUDGET;
CHILD;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DEATH;
DISEASE ASSOCIATION;
DRUG COST;
DRUG SENSITIVITY;
FEASIBILITY STUDY;
FEMALE;
GASTRITIS;
HEADACHE;
HEALTH PROGRAM;
HUMAN;
INCOME;
INSOMNIA;
MAJOR CLINICAL STUDY;
MALE;
MULTIDRUG RESISTANCE;
NAUSEA;
PATIENT CARE;
PATIENT COMPLIANCE;
PERU;
PRIORITY JOURNAL;
RASH;
RISK ASSESSMENT;
SIDE EFFECT;
STANDARDIZATION;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TUBERCULOSIS;
VERTIGO;
VISUAL IMPAIRMENT;
VOMITING;
|
|
EID: 0037042497
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(02)08830-X Document Type: Article |
|
Times cited : (222)
|
|
References (39)
|
